Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Eli Lilly and Company
*STREET
Lilly Corporate Center
*CITY
Indianapolis
*STATE
(Required for U.S. applicants)
Indiana
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
46285
PHONE
317-651-1346
FAX
317 276 1919
EMAIL ADDRESS
trademarks@lilly.com
WEBSITE ADDRESS
www.lilly.com
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Indiana
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis,
autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease,
dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia,
inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and
disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic
arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic
preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT
The mark is a coined, non-dictionary word with no English translation.
ATTORNEY INFORMATION
NAME
Bruce W. Longbottom
FIRM NAME
Eli Lilly and Company
STREET
Lilly Corporate Center
CITY
Indianapolis
STATE
Indiana
COUNTRY
United States
ZIP/POSTAL CODE
46285
PHONE
317-651-1346
FAX
317 276 1919
EMAIL ADDRESS
trademarks@lilly.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
John R. Rudolph, Steven P. Caltrider, Gilbert T. Voy, Tonya L. Combs
CORRESPONDENCE INFORMATION
NAME
Bruce W. Longbottom
FIRM NAME
Eli Lilly and Company
STREET
Lilly Corporate Center
CITY
Indianapolis
STATE
Indiana
COUNTRY
United States
ZIP/POSTAL CODE
46285
PHONE
317-651-1346
FAX
317 276 1919
*EMAIL ADDRESS
trademarks@lilly.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
275
*TOTAL FEE PAID
275
SIGNATURE INFORMATION
SIGNATURE
/blongbottom/
SIGNATORY'S NAME
Bruce W. Longbottom
SIGNATORY'S POSITION
Assistant General Counsel
SIGNATORY'S PHONE NUMBER
317-651-1346
DATE SIGNED
07/31/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88554919
Filing Date:07/31/2019
To the Commissioner for Trademarks:
MARK: YOBEKRA (Standard Characters, see mark)
The literal element of the mark consists of YOBEKRA.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Eli Lilly and Company, a corporation of Indiana, having an address of
Lilly Corporate Center
Indianapolis, Indiana 46285
United States
317-651-1346(phone)
317 276 1919(fax)
trademarks@lilly.com (not authorized)
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic
dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's
disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia,
inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and
disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic
arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic
preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Miscellaneous Statement
The mark is a coined, non-dictionary word with no English translation.
For informational purposes only, applicant's website address is: www.lilly.com
The applicant's current Attorney Information:
Bruce W. Longbottom and John R. Rudolph, Steven P. Caltrider, Gilbert T. Voy, Tonya L. Combs of Eli Lilly and Company Lilly
Corporate Center
Indianapolis, Indiana 46285
United States
317-651-1346(phone)
317 276 1919(fax)
trademarks@lilly.com (authorized)
The applicant's current Correspondence Information:
Bruce W. Longbottom
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
317-651-1346(phone)
317 276 1919(fax)
trademarks@lilly.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /blongbottom/ Date: 07/31/2019
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Assistant General Counsel
Payment Sale Number: 88554919
Payment Accounting Date: 07/31/2019
Serial Number: 88554919
Internet Transmission Date: Wed Jul 31 15:11:49 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2019073115114983
0095-88554919-62018e19b691ac6137c8f991d7
16f735f3bfdb63634a573f25264c56f4140b278a
8-DA-11491235-20190731114100242076